Prof. Dr. Giulio Superti-Furga is the Scientific Director of CeMM and Professor for Medical Systems Biology at the Center for Physiology and Pharmacology (Medical University of Vienna). He has >25 years of experience in the use of chemical biology and omics techniques to understand drug action. He co-founded the biotech companies Cellzome, Haplogen, Allcyte(now Exscientia),Proxygen and Solgate. He was responsible for several large-scale projects such as genome-wide characterization of the yeast protein complexes, mapping of the entire NF-κB pathway, the viral interactome, organization of the human lipidome and global genetic interaction map of Solute Carrier transporters (SLCs). After characterizing SLC transporters required for drugs to enter cells and other required to couple nutrient availability to mTOR activity, he became an advocate of more research on SLC transporters. He has been awarded two ERC Advanced grants and two ERC Proof of Concept grants. He is the academic coordinator of the Innovative Medicines Initiative (IMI) consortia “RESOLUTE” focusing on SLCs, and the extension “REsolution” focusing on human genetic variations of SLCs involved in disease.